Biocon stocks gain over 5%, hit 52-week high in intra-day trade
Stocks of biotechnology major Biocon on Thursday surged over 5 percent after the company launched advanced novel therapy for the treatment of Hepatitis C at low cost.
Dec 24, 2015, 18:02 PM IST